Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-D-glucosaminyl group inhibits UCHL3. 1 / 1

| 1

➶

sparser

"As LDN can also inhibit UCHL3, we determined the UCHL3 protein level in the sham group and MI group 14 days after operation and found that no significant differences between the two groups (Supplemental Fig. xref )."

32606430

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...